1. Screening for diabetic retinopathy with different levels of financial incentive in a randomized controlled trial
- Author
-
Wendy Wing Sze Tsui, Jinxiao Lian, Alfred S K Kwong, Ching So, Jonathan C.H. Chan, Rita Sum, Sarah M. McGhee, and David Vai Kiong Chao
- Subjects
Male ,Financial incentive ,Randomization ,Endocrinology, Diabetes and Metabolism ,Uptake ,030209 endocrinology & metabolism ,Severity of Illness Index ,Diseases of the endocrine glands. Clinical endocrinology ,law.invention ,Diabetic retinopathy screening ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Diabetes mellitus ,Internal Medicine ,medicine ,Humans ,Mass Screening ,Retrospective Studies ,Finance ,Motivation ,Diabetic Retinopathy ,Primary Health Care ,business.industry ,Significant difference ,General Medicine ,Diabetic retinopathy ,Odds ratio ,Articles ,Middle Aged ,medicine.disease ,Prognosis ,RC648-665 ,Incentive ,Clinical Science and Care ,Diabetes Mellitus, Type 2 ,Case-Control Studies ,030221 ophthalmology & optometry ,Hong Kong ,Female ,Original Article ,business ,Follow-Up Studies - Abstract
Aims/Introduction To examine the impact of different levels of financial incentive in terms of fee subsidization on diabetic retinopathy screening in the private primary care setting in Hong Kong. Materials and Methods All general practitioners working in the private sector and registered in two electronic public databases were invited to participate. Consecutive patients with diabetes mellitus were then recruited by the participating practitioners. The recruited participants were randomly allocated to one of three screening groups with different fee levels (HK$0, HK$150 [US$19], HK$300 [US$39]) in a randomized controlled trial. Screening uptake and severity of diabetic retinopathy detected were compared. Results Out of 1,688 eligible practitioners, 105 participated and invited 402 patients, with 239 initially agreeing to participate (59.5%). After randomization, 78, 75 and 76 participants in the HK$0, HK$150 and HK$300 fee groups, respectively, reconfirmed their participation and were offered screening at the relevant fee. The uptake of screening was 79.5% (62/78), 81.3% (61/75) and 63.2% (48/76), in the HK$0, HK$150 and HK$300 groups, respectively (P, A half subsidized diabetic retinopathy screening service appears to be sustainable, with comparable uptake to full subsidization, including those with high diabetic retinopathy risk, while using less medical expenditure.
- Published
- 2021